Regencell Bioscience Lim...

NASDAQ: RGC · Real-Time Price · USD
850.50
-26.50 (-3.02%)
At close: Jun 02, 2025, 9:57 AM

Regencell Bioscience Revenue

Regencell Bioscience reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2024, Regencell Bioscience generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
12
Market Cap
11.07B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.